Category Archives: The IPO Buzz

Gene therapy startup Lexeo Therapeutics (LXEO) priced its IPO at $11.00 – $2.00 below the low end of its $13.00-to-$15.00 range – on Thursday night, Nov. 2, 2023. Lexeo Therapeutics slightly increased the number of shares to 9.09 million – up from 9.0 million in the prospectus – to raise $100.0 million. The deal raised […]

Bermuda-based Hamilton Insurance Group, Ltd. (HG proposed) launched its $255 million IPO early today (Wednesday, Nov. 1, 2023) by disclosing terms: 15.0 million Class B common shares at $16.00 to $18.00. (Source: S-1/A filing dated Nov. 1, 2023) The IPO is scheduled for pricing next week – on Thursday night, Nov. 9, to trade Friday, […]

Alpha Technology Group Ltd. (ATGL) opened flat at $4.00 – its IPO price – at 10:45 a.m. EDT today and quickly rose to $4.54 in its NASDAQ debut on Halloween (Tuesday,  Oct. 31, 2023). Before noon EDT, Alpha Technology Group’s stock popped above $5.00. At around 12:34 p.m. EDT, the stock hit $6.54 – its session […]

Biotech Lexeo Therapeutics (LXEO proposed) launched its $126 million IPO today -Monday, Oct. 30, 2023 – for pricing this week. Lexeo Therapeutics disclosed its IPO terms – 9.0 million shares at $13.00 to $15.00 – in an S-1/A filing early today. The news injected some life – and the only $100-million-plus IPO – into the […]

Mach Natural Resources LP (MNR), an Oklahoma City-based oil and natural gas partnership, priced its IPO at $19.00 – the low end of its $19.00-to-$21.00 range – on Tuesday night (Oct. 24, 2023). The profitable oil and gas drilling company priced 10 million units – the same number in the prospectus – at $19.00 to raise […]

Oklahoma City-based Mach Natural Resources LP (MNR proposed), an oil and natural gas limited partnership, is the featured attraction this week. Mach is the only big traditional deal on the IPO Calendar for the week of Oct. 23, 2023. Mach is offering 10 million common units at $19.00 to $21.00 to raise $200 million – […]

French biotech Abivax S.A. (ABVX) priced its NASDAQ uplisting – a U.S. public offering of 18.7 million American Depositary Shares (ADS) – at $11.60 – the low end of its range – to raise $216.91 million on Thursday night (Oct. 19, 2023). The price range was $11.60 to $13.00 for the ADS. Abivax S.A.’s ADS […]

To the moon: Singapore-based WeBuy Global Ltd. (WBUY) shares jumped to $10.00 – for a moonshot gain of 150 percent from their $4.00 IPO price – at around 12:45 p.m. EDT today in their NASDAQ debut. Volume was about 1.09 million shares. The stock hit its intraday high at $10.84 at around 3:10 p.m. EDT. Within a […]

Northann Corp. (NCL), a California manufacturer and distributor of 3D-printed vinyl flooring, priced its sharply downsized IPO at $5.00 – the high end of its $3.00-to-$5.00 range – to raise $6.0 million on Wednesday night (Oct. 18, 2023). The company cut the number of shares by 60 percent – to 1.2 million shares – down from […]

Abivax S.A., a French biotech whose ulcerative colitis drug candidate is in Phase 3 clinical trials, aims to raise $250 million in its NASDAQ uplisting this week. Abivax (ABVX proposed) launched its U.S. public offering of 18.68 million American Depositary Shares (ADS) on Monday (Oct. 16, 2023) by disclosing terms and starting its roadshow. The […]